An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles directly for source information, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where groups with numerous of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before directing buyers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Experts Voice Worries
However, physicians and pharmacists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.
Some professionals stated the demand for the experimental drug could be connected to the rising cost of licensed slimming products such as Mounjaro.
Legal Position and Implementation
Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or distributed for human use under the British medical regulations.
Some content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach pharmaceutical, marketing, and customer regulations, risking penalties, prosecution or prison.
Platform Reaction and Material Removal
Based on TikTok, the service has removed problematic content and banned related keywords and query recommendations. The company stated it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies.
Online Trading Activities
Investigations also discovered groups with up to 9,000 participants selling retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of members, filled with photos of slimming results, glowing testimonials and step-by-step guides for mixing or administering at residence.
Within moments of entering one community, a seller shared contact information, where most transactions take place. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.
Product Information and Pricing
Within these communities, messages show dark colored packages with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with sterile water, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how long a injector should last, vendors give conflicting answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for the messaging service stated it regularly moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are injecting substances they cannot confirm. Even if the research behind retatrutide is valid, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But fake treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.
Her staff has previously seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company experimental substance not yet authorized … may subject users to possibly significant medical dangers”.
